| Execution period | 60 months from 2027-04-01 |
|---|
NSE filing, NSE: ATUL. Summary written from the filing by ALFA Finder's alert engine.
Atul Ltd: key numbers
- Share price
- ₹5,208.00
- Market cap
- ₹15,333 Cr
- Revenue (annual)
- ₹6,274 Cr
- Net profit (annual)
- ₹677.9 Cr
- P/E (TTM)
- 19.9×Sector 34.5×
- Promoter holding
- 45.33%+0.00% QoQ
- FII holding
- 8.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Atul Ltd
All →Atul Capital Structure Change
Atul's board approved a buyback of 1,20,000 equity shares at Rs 7,500 each, up to Rs 90 Crore. The buyback will be executed through the open market.
- Value
- ₹90.00 Cr
Atul Q2 FY27 Results: Net Profit ₹158.7 Cr, Down 13.0% YoY
Atul Ltd reported revenue from operations of ₹1,877 Cr (+21.0% YoY) and net profit of ₹158.7 Cr (-13.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹158.7 Cr · -13.0% YoY
Atul Legal & Regulatory
Atul Ltd received directions from the Gujarat Pollution Control Board regarding a pipeline damage incident. The company expects no material impact and has completed repairs.
- Value
- ₹0.10 Cr
Atul Board Meeting Date
Atul Ltd informed the stock exchanges that its Board will meet on October 23, 2026, to consider a proposal for a buy-back of equity shares.
Atul Price Movement Clarification
Atul Ltd clarified that an accidental damage in its effluent pipeline caused a brief release of treated discharge. Repairs are underway, and no material impact is expected.
Atul Other Announcement
Atul Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.